The store will not work correctly when cookies are disabled.
5-methyl-6-(phenylethynyl)-pyridine
ID: ALA4102569
PubChem CID: 53990350
Max Phase: Preclinical
Molecular Formula: C14H11N
Molecular Weight: 193.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccnc1C#Cc1ccccc1
Standard InChI: InChI=1S/C14H11N/c1-12-6-5-11-15-14(12)10-9-13-7-3-2-4-8-13/h2-8,11H,1H3
Standard InChI Key: KEKSJWYNZNCANZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
13.9872 -20.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5745 -20.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9872 -19.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8085 -19.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2171 -20.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8085 -20.7813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0384 -20.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8597 -20.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6852 -20.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0938 -19.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9151 -19.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3278 -20.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9151 -20.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0938 -20.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2171 -18.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 3 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
8 9 1 0
5 7 1 0
4 15 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 193.25 | Molecular Weight (Monoisotopic): 193.0891 | AlogP: 2.79 | #Rotatable Bonds: ┄ |
Polar Surface Area: 12.89 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 1 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.52 | CX LogP: 3.78 | CX LogD: 3.78 |
Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.59 | Np Likeness Score: -1.04 |
References
1. Felts AS, Rodriguez AL, Blobaum AL, Morrison RD, Bates BS, Thompson Gray A, Rook JM, Tantawy MN, Byers FW, Chang S, Venable DF, Luscombe VB, Tamagnan GD, Niswender CM, Daniels JS, Jones CK, Conn PJ, Lindsley CW, Emmitte KA.. (2017) Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation., 60 (12): [PMID:28530802] [10.1021/acs.jmedchem.7b00410] |